MJC13
MJC13 is an FKBP52-targeted agent with anti-tumor activity that can be used in prostate cancer research[1].
Product Specifications
CAS Number
[200709-97-3]
UNSPSC
12352005
Hazard Statement
H302-H319
Target
FKBP
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation
Field of Research
Cancer
Smiles
C1CCC(CC1)C(=O)NC2=C(C(=CC=C2)Cl)Cl
Molecular Formula
C13H15Cl2NO
Molecular Weight
272.17
Precautions
P264-P270-P280-P330-P501
References & Citations
[1]Su Liang, et al. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016;21 (1) :121-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1049620-01 0.02 mg (E-Coli)
Recombinant Opitutus terrae 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Ask
View Details MBS1049620-02 0.02 mg (Yeast)
Recombinant Opitutus terrae 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Ask
View Details MBS1049620-03 0.1 mg (E-Coli)
Recombinant Opitutus terrae 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Ask
View Details